Holen Sie sich die Stockscreener-App
24.86
0.24%
0.06
Handel nachbörslich:
24.87
0.01
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$24.80
Offen:
$24.97
24-Stunden-Volumen:
54.72M
Relative Volume:
1.63
Marktkapitalisierung:
$140.17B
Einnahmen:
$59.37B
Nettoeinkommen (Verlust:
$4.25B
KGV:
13.58
EPS:
1.83
Netto-Cashflow:
$8.23B
1W Leistung:
-5.26%
1M Leistung:
-14.92%
6M Leistung:
-13.20%
1J Leistung:
-16.91%
1-Tages-Spanne:
$24.70
$25.25
1-Wochen-Bereich:
$24.48
$26.85
52-Wochen-Spanne:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Firmenname
Pfizer Inc
Sektor
Telefon
(212) 733-2323
Adresse
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Vergleichen Sie PFE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PFE | 24.86 | 140.17B | 59.37B | 4.25B | 8.23B | 1.83 |
| LLY | 727.20 | 683.37B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 99.81 | 446.14B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 154.77 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 166.28 | 293.80B | 55.53B | 5.12B | 15.62B | 3.65 |
| MRK | 96.56 | 242.49B | 63.17B | 12.15B | 14.84B | 1.80 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | Fortgesetzt | UBS | Neutral |
| 2023-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-17 | Bestätigt | JP Morgan | Neutral |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-06-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | Eingeleitet | Jefferies | Hold |
| 2023-02-07 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | Herabstufung | UBS | Buy → Neutral |
| 2023-01-17 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-01-03 | Bestätigt | Bernstein | Mkt Perform |
| 2021-12-20 | Bestätigt | Cowen | Outperform |
| 2021-12-17 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-12-16 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | Fortgesetzt | Goldman | Neutral |
| 2020-11-10 | Fortgesetzt | Bernstein | Mkt Perform |
| 2020-10-12 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-06-16 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-02-27 | Hochstufung | Standpoint Research | Hold → Buy |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-07-30 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-02-20 | Fortgesetzt | Citigroup | Neutral |
| 2019-01-31 | Hochstufung | Argus | Hold → Buy |
| 2019-01-31 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | Herabstufung | UBS | Buy → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
Alle ansehen
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’ - Insider Monkey
Pfizer (NYSE:PFE) Stock Price Up 0.6%Here's What Happened - MarketBeat
Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now? - Yahoo Finance
2 High-Yield Dividend Stocks I Can't Stop Buying - The Motley Fool
TrinityPoint Wealth LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Hidradenitis Suppurativa Market to Reach $1.1 Billion by 2031 | - openPR
Medicus Pharma unveils ex-GSK and Pfizer senior as chief medical officer - Proactive Investors USA
Swiss National Bank Purchases 100,900 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Bought by Atlanta Consulting Group Advisors LLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Kentucky Retirement Systems - MarketBeat
CIBC Asset Management Inc Has $30.83 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Rep. Greg Landsman Sells Pfizer Inc. (NYSE:PFE) Shares - MarketBeat
Pfizer Inc - Reuters.com
Pfizer Inc. stock underperforms Friday when compared to competitors - MarketWatch
Moderna, Pfizer pharma stock dips after RFK Jr. nominated to lead HHS - Healthcare Brew
Pfizer (NYSE:PFE) Trading Down 3.8%Here's Why - MarketBeat
Pfizer (PFE) technical analysisPfizer (NYSE:PFE) - Benzinga
Big Pharma Reckoning Looms With RFK Jr. Eyeing Pfizer (NYSE:PFE) - Seeking Alpha
Friday's Top 5 Trending Stocks: What's The Scoop On Palantir, Bloom Energy, Pfizer? - Benzinga
Pfizer (NYSE:PFE) Reaches New 12-Month LowHere's What Happened - MarketBeat
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Valley Wealth Managers Inc. Increases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Empowered Funds LLC Has $14.71 Million Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer stock hits 52-week low at $25.14 amid market challenges By Investing.com - Investing.com South Africa
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Pfizer stock hits 52-week low at $25.14 amid market challenges - Investing.com Canada
Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Pfizer (NYSE:PFE) Coverage Initiated by Analysts at Wolfe Research - MarketBeat
ING Groep NV Lowers Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
EU Rejects Showing Texts Sent to Pfizer CEO in Transparency Test - Bloomberg
Court Hears New York Times Case Against European Commission Over Vaccine Deal - The New York Times
Keytruda Market Overall Study Report 2024-2032 | Roche Holding - openPR
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Las Vegas woman sues Pfizer, claiming birth control shot caused brain tumors - Las Vegas Review-Journal
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination - The Wall Street Journal
Investors Buy High Volume of Pfizer Put Options (NYSE:PFE) - MarketBeat
Cambridge firefighters respond to hazmat incident at Pfizer building - The Boston Globe
With RFK Jr. Set To Join Trump’s Team, Pfizer, Moderna, And Other Vaccine Stocks Slump - Times Now
Pfizer (NYSE:PFE) Trading Down 1%Here's Why - MarketBeat
Is Pfizer Stock A Sell After Covid Products Drive Surprise Upside? - Investor's Business Daily
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference - Yahoo Finance
KBC Group NV Acquires 639,985 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Huntington National Bank Has $21.43 Million Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Bell Bank Decreases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
PFIZER INC : UBS remains Neutral - Marketscreener.com
Victory Capital Management Inc. Sells 856,415 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Aptus Capital Advisors LLC Sells 159,292 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
UTI treatment Market Overall Study Report 2024-2032 | Pfizer, - openPR
Entropy Technologies LP Purchases Shares of 29,711 Pfizer Inc. (NYSE:PFE) - MarketBeat
Entropy Technologies LP Makes New $860,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
Finanzdaten der Pfizer Inc-Aktie (PFE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):